Phase I trial of continuously infused gemcitabine with CPT-11 for refractory hematologic malignancies.
Journal Article
Full Text
Duke Authors
Cited Authors
- Rizzieri, DA; Gockerman, JP; Decastro, CM; Lilly, S; Foster, T; Adams, D; Moore, JO
Published Date
- November 16, 2000
Published In
Volume / Issue
- 96 / 11
Start / End Page
- 216B - 216B
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 0006-4971
Language
- English